Quoin Pharmaceuticals, Ltd. (QNRX) stock: key figures, P/E, revenue and dividend
Health Care · ISIN US74907L1026
Quoin Pharmaceuticals, Ltd. financials
| Fiscal year | 2025 |
|---|---|
| EBIT | -15.80 m USD |
| Net income | -15.80 m USD |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
More stocks
- Hawkeye Systems, Inc. (HWKE)
- SURGE COMPONENTS INC (SPRS)
- VEEA INC. (VEEA)
- Brilliant Earth Group, Inc. (BRLT)
- Charlie's Holdings, Inc. (CHUC)
- PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
- STRATEGIC ACQUISITIONS INC /NV/ (STQN)
- Fold Holdings, Inc. (FLD)
- Coronado Global Resources Inc. (CODQL)
- HWH International Inc. (HWH)
- SELECTIS HEALTH, INC. (GBCS)
- CareView Communications Inc (CRVW)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.